GET THE APP

Editorial Note for Medicinal Biotechnology
..

Molecular and Genetic Medicine

ISSN: 1747-0862

Open Access

Editorial Note - (2021) Volume 15, Issue 2

Editorial Note for Medicinal Biotechnology

Rita B*
*Correspondence: Rita B, G. Pulla Reddy College of Pharmacy, Hyderabad, India, Email:
G. Pulla Reddy College of Pharmacy, Hyderabad, India

Received: 15-Feb-2021 Published: 27-Feb-2021 , DOI: 10.37421/1747-0862.2021.15.479
Citation: Badigeru, Rita. “Editorial Note for Journal of Molecular and Genetic Medicine.” J Mol Genet Med 15 (2021): 479.
Copyright: © 2021 Rita B. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Editorial Note

The Journal of Molecular and Genetic medicine gives you continuous coverage of all genetic and molecular aspects of medicine as well as in-depth documentation of gene therapy within the current context of genotype/ phenotype correlations. In addition to this, publishes articles related to neurogenetics, cardiogenetics, gene therapy, medical genetics, etc. covering experimental and clinical investigations of the genetic mechanisms underlying genetic syndromes.

Medicinal biotechnology aims to produce pharmaceutical and diagnostic products for the prevention and treatment of human diseases using living cells and cell materials. The areas of application of medicinal biotechnology are genetic testing, drug production, gene therapy and pharmacogenomics. One of the major uses in biotechnology is for medicinal purposes. Modern applications of biotechnology continue to find promising new uses in the medicinal and health care fields. Modern biotechnology can be used to manufacture drugs more easily and cheaply, as they can be produced in larger quantities from existing genetic sources.

Medical biotechnology is a branch of medicine that uses living cells and cell materials to research, and then produces pharmaceutical and diagnosing products. These products help treat and prevent diseases. From the Ebola vaccine to mapping human DNA to agricultural impacts, medial biotechnology is making huge advancements and helping millions of people.

Recombinant DNA technology is combining DNA molecules from two different species, and then inserting that new DNA into a host organism. That host organism will produce new genetic combinations for medicine, agriculture, and industry. There are many examples of recombinant DNA technology being utilized, from biopharmaceuticals and diagnostics, to energy applications like biofuel, to agricultural biotechnology with modified fruits and veggies. The genetically modified products are able to perform better than the regular medicine or produce.

Journal of Molecular and Genetic medicine provides a scientific approach for advanced studies of rare and common disorders which will make research studies in this area easily and quickly accessible to the scientific community. This will serve as the basis for high level studies into individualized diagnostics and therapeutics, for day-to-day medical care.

Journal of Molecular and Genetic medicine is an Open Access journal peer reviewed publishing high quality research with speed and efficiency. This journal is using Editorial Tracking System for quality online manuscript submission, review and tracking article status. Authors pay Article Publication Charge once it gets acceptance after peer review process with at least two independent reviewer’s approval followed by the editor’s approval and their papers are published under a Creative Commons license. With Creative Commons licenses, the author retains copyright and the public is allowed to reuse the content.

All published articles of this journal are included in the indexing and abstracting coverage of Index Copernicus, Google Scholar, Cite Factor, Sherpa Romeo, Genamics JournalSeek, Academic Keys CiteFactor, Ulrich's Periodicals Directory, Electronic Journals Library RefSeek, Hamdard University, EBSCO A-Z, Directory of Abstract Indexing for Journals, OCLC- WorldCat, Proquest Summons, ROAD, Virtual Library of Biology (vifabio), Publons Studies receiving funding from a funding organization that is included on the list of PMC and Research Funder Policies or authors having NIH grant were submitted to PubMed.

I am very much delighted to inform that, all issues of volume 14 were published online well within the prescribed time and the print issues were also brought out and dispatched within 30 days of publishing the issue online during the year of 2020. I would also like to congratulate all the authors, reviewers, the publisher, the advisory and the editorial board of Journal of Molecular and Genetic Medicine for their immense support to bring out the Volume 15, Issue 2 of Journal of Molecular and Genetic Medicine in scheduled time.

Google Scholar citation report
Citations: 3919

Molecular and Genetic Medicine received 3919 citations as per Google Scholar report

Molecular and Genetic Medicine peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward